Expedited Access to Biosimilars Act

United States119e CongrèsS-1414Senate
Mis à jour : 27 juill. 2026

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Consulter le texte officiel

2 versions disponibles

Tous les dossiers disponibles sont affichés.

Chronologie

Dernière mesure du projet de loi complémentaire

HR-9661: Expedited Access to Biosimilars Act

Referred to the House Committee on Energy and Commerce.

  1. Introduced in Senate

  2. Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Senate

  3. Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

    Senate

  4. Placed on Senate Legislative Calendar under General Orders. Calendar No. 520.

    Senate